is the density of the 3,3'-diaminobenzidine (DAB) label, which obscures intracellular details of labeled structures. To overcome this problem, a silver enhancement protocol was developed which leaves silver deposits on very low levels of DAB. The resulting label is composed of easily visualized punctate silver deposits, localized in processes with little or no detectable DAB. This technique incorporates several modifications into previously described methods for silver enhancement of DAB. The principal innovation is to pretreat the DAB label with sodium sulfide before silver enhancement, which substantially increases the sensitivity of the silver enhancement. In addition, cysteine was used in place of thioglycolic acid to suppress tissue argyrophilia, allowing use of both glutaraldehydeand paraformaldehydefiied tissue without degradation of ultrastructure. We demonstrate this technique with dopamine, norepinephrine 1993)
Introduction
Although several alternative labels are now available for immunoelectron microscopy (IEM) of neural tissue, the standard method is to treat tissue with peroxidase-linked antibodies, which are then visualized with the substrate 3,3'-diaminobenzidine (DAB) (Graham and Karnovsky, 1966) . The advantages of DAB are multiple; it is easy to apply, it is stable, it provides good contrast for both LM and EM, it penetrates tissue well, and it can be used to accurately distinguish even very small processes. Other labels are suitable for certain applications but are not as versatile. For example, tetramethylbenzidine or benzidine dihydrochloride can be used for labeling cell bodies and bigger profiles, but their large, widely spaced crystals make it difficult to identify small neural processes (Levey (NE), and serotonin (5HT) immunoreactivity in monkey prefrontal cerebral Cortex and with dopamine immunoreactivity in the anterior caudate. The punctate label allows essentially unobscured visualization of the intracellular details and cell membranes of these monoamine axons. Whereas 5HT axons formed small asymmetric synapses, dopamine and NE axom typically formed small symmetric synapses with notably subtle membrane specializations. It is likely that these are often obscured by conventional DAB labeling. The use of several preparations indicates that this technique will be useful with a variety of antibodies. It might also provide an attractive alternative to colloidal gold, especially with glutaraldehyde-fmed tissue which is not easily penetrated by gold particles. (J Histochem Cytochem 41 :1393-1404, Carson and Mesulam, 1982) . Antibodies can also be conjugated to gold particles or to ferritin, but these are usually not visible by LM and they penetrate fixed tissue rather poorly (reviewed in Leranth and Pickel, 1989) . The latter problems have only partially been overcome by using very small gold particles with subsequent silver enhancement (Chan et al., 1990; van den Pol, 1985 van den Pol, , 1986 . Post-embedding immunocytochemistry is now widely used but is useful only for certain antigens (Ottersen, 1987; Somogyi and Hodgson, 1985) . Another approach is immunoautoradiography, but this incorporates the problems of long exposure times and scatter of silver grains (Pickel et al., 1986) .
Despite the advantages of DAB, a common frustration is that it obscures intracellular structures and the fine details of the cell membrane. This is a problem especially for visualization of synapses, which are usually identified by presynaptic accumulation of vesicles and by changes in the pre-and postsynaptic cell membranes, which can be very subtle. Therefore, we developed a technique for IEM which retains the use of DAB with its advantages and improves the resolution of the labeled process. For this pur-pose, several modifications were made in previously described procedures for silver enhancement of DAB for EM Liposits et al., 1984 Liposits et al., ,1986 van den Pol and Gorcs, 1986) . These modifications allow silver precipitation on very low levels of DAB that do not obscure the labeled process. We demonstrate the use of this technique in tissue fixed in either glutaraldehyde or mainly paraformaldehyde, with different antibodies to monoaminergic axons.
Materials and Methods

Tissue Sources
Neural tissue was taken from both monkey and human sources. Two adult rhesus macaques were deeply anesthetized with sodium pentobarbital and perfused. The first was perfused with 5% glutaraldehyde, 1% sodium metabisulfite (NazSz05), 0.1 M phosphate buffer, pH 7.4, and the second with 4% paraformaldehyde, 0.08% glutaraldehyde, 0.1 M phosphate buffer, pH 7.4. Small blocks from both monkeys were removed from the principle sulcus of the prefrontal cerebral cortex (Area 46 of Walker, 1940) and from the anterior head of the caudate, and were post-fixed for 2 hr in the same fixative used for perfusion. Human tissue was used in some preliminary experiments, consisting of small pieces of anterior lateral temporal cortex, removed during surgery and fixed and processed as previously described (Smiley et al., 1992) . Briefly, thin pieces of cortex were immersed (4°C. overnight) in 4% glutaraldehyde, 0.2% picric acid, 1% Na2S205, 0.1 M cacodylate, pH 7. After fixation both monkey and human tissue was vibratome-sectioned at 50 Bm, exposed to 1% NaB& for 10 min, rinsed thoroughly, and then briefly immersed in a minimal volume of 15% sucrose before exposure to two cycles of freezing and thawing to enhance antibody penetration. In each cycle, tissue sections were rapidly frozen by placing the glass vial that contained them in liquid nitrogen, and were then thawed at room temperature. Sections were usually stored after the second freezing at -70'C until needed. All solutions used with glutaraldehydefixed tissue, up to and including the solution in which anti-dopamine was applied, also contained 1% Na2SzO5 to prevent oxidation of dopamine (Van Eden et al., 1987) . Human tissue was obtained with the informed consent of the patients and with the approval of the Yale institutional review board of the Human Investigations Committee. Monkeys were maintained and used with regard to NIH Guidelines for animal research and in accordance with the Yale University Animal Care Committee.
Antibodies
Labeling of glutaraldehyde-fixed tissues with glutaraldehyde-conjugated antibodies was done with anti-norepinephnne (NE) from Chemicon (Temecula, CA), or with anti-dopamine or anti-serotonin (5HT) generously provided by M. Geffard. The specificities of the latter antibodies were described in Chagnaud et al. (1987) and Geffard et al. (1985) . In addition to these antibodies, paraformaldehyde-conjugated anti-5HT purchased from Incstar (Stillwater, MN) was used to label tissue fived in 4% paraformaldehyde with 0.08% glutaraldehyde.
Anti-dopamine was a mouse monoclonal (MAb) used at a final concentration of 1:10.000, and anti-NE was a rabbit polyclonal antibody used at 1:5000. The anti-5HT of Geffard et al. (1985) was a rabbit polyclonal used at 1:20,000, and the anti-5HT from Incstar was a rabbit polyclonal used at 1:5000. All antibodies were applied for 2 or more days at 4°C in 1% BSA, 0.1% glycine, 0.1% lysine, and 0.3% normal serum, with 0.1 M Tris, pH 7.4. For dopamine labeling, 1% NazS2Or was also present. All subsequent immunolocalization was done with ABC-Elite kits from Vector (Burlingame, CA).
Electron Microscopy
After immunolabeling, tissue was exposed for 15 min to 1% Os04 with 0.08% potassium ferricyanide in 0.1 M phosphate buffer (PB), pH 7.2. After several rinses in PB, the tissue was dehydrated and embedded in Durcupan ACM resin and mounted with glass slides and coverslips pre-treated with liquid release agent (Electron Microscopy Sciences; Ft Washington, PA). Selected areas were cut out with a razor, remounted, and serial sectioned. Sections were collected on formvar-coated one-hole grids and counterstained with lead citrate and uranyl acetate.
Siluer Enhancement Protocol
The procedure for silver enhancement of DAB was adapted from Liposits et al. (1984) (see also Gorcs et al., 1986; Liposits et al., 1986; van den Pol and Gorcs, 1986; Gallyas, 1982b) . The procedure for preparation and use of the physical developer described by those authors was retained but modifications were made in the treatment of the tissue before physical development and in the length of the treatments to stabilize the silver afterwards ( Figure 1 ). The following paragraphs describe in detail the individual steps and modifications made in this procedure. A final recommended procedure is then summarized.
Preparation of the Physical Developer. As in Liposits et al. (1984) , the physical developer contained the following components, made up in doubledistilled water (DDW). We found it convenient to make Solutions A and B in clean disposable 50-ml Falcon tubes: Solution A was 5% sodium carbonate from anhydrous crystals. For Solution B, to 50 ml add and dissolve the following reagents in the order listed: 0.1 g ammonium nitrate, 0.1 g silver nitrate, and 0.5 g tungstosilicic acid [Fisher (Fairlawn, NJ) or Merck (Darmstadt, Germany)]. Solution C was 37% formaldehyde.
These solutions can be made ahead of time but should be mixed immediately before use as follows: stirring constantly, add 40 pl of C dropwise to 10 ml of B, which is then added dropwise to 10 ml of A, also with stirring. A useful technique for mixing these solutions is to use a clean disposable petri dish, held and agitated with one hand, while adding the other solution dropwise with a clean disposable pipette. If the developer becomes cloudy it should be discarded. After the solutions are mixed, transfer aliquots to fresh petri dishes and transfer the tissue sections to these with a clean glass rod. In our hands the most common cause of bad developer is the introduction of some kind of contamination, and for this reason it is advisable to avoid using a stir bar. Gorcs et al. (1986) stressed the importance of good-quality tungstosilicic acid stored under desiccation at -20°C. In general, we found the results to be quite reliable, providing caution is exercised to exclude impurities.
Tissue &e-incubation with Cysteine to Reduce Tissue Argymphdia. Silver enhancement of DAB in tissue requires a pre-treatment to reduce silver precipitation by argyrophilic sites in the tissue. Previous studies found that thioglycolic acid was very effective for this purpose compared with several other acidified mercapto compounds (Gallyas, 1982b) . In the present experiments we observed that even short exposures to thioglycolic acid ruined the ultrastructure of glutaraldehyde-fixed tissue. Therefore, an alternative mercapto compound was sought to suppress tissue argyrophilia. For this purpose some of the experiments of Gallyas (1982b) were replicated. Human cortical sections fixed in 5 % glutaraldehyde were exposed for 3 h to 0.05 M thioglycolic acid, cysteine (L-cysteine) (Sigma; St Louis, MO), 2-mercaptoethanol, or thioglycerol. Each compound was brought to pH 3 by addition of hydrochloric acid except thioglycolic acid, which was brought up to pH 3 by addition of 0.1 M Bizma-8.0 (Sigma). After these treatments the sections were exposed to silver developer until a dark silver precipitate appeared on the edge of the sections. Thioglycolic acid was most effective in delaying silver precipitation (15 min) and thioglycerol(11 min) was slightly better than cysteine (10 min), whereas 2-mercaptoethanol was the least effective (4 min). Untreated sections had a dark silver precipitate at 1.5 min. Except for the ineffectiveness of 2-mercaptoethanol, these results were in good agreement with those of Gallyas (1982b) . Some sections were processed for EM, and the ultrastructure of cysteine-and thioglycerol-treated tissue was comparable to that of control tissue. Cysteine was chosen over thioglycerol for further experiments because it is a commonly available compound and does not have a strong unpleasant odor.
For the labeling described here, cysteine was effective when applied for 5 hr as a 5% solution (pH 2.75). With these conditions and after sodium sulfide treatment (described below). background silver precipitation onto tissue sections was not seen until after 7-10-min incubation in the developer. Because 4-5 min was optimal for enhancing the DAB label, this cysteine treatment was satisfactory. Use of cysteine at a slightly lower pH appeared to decrease immunolabeling in some cases, possibly due to dissociation of bound primary and secondary antibodies from the tissue. Therefore, although these conditions were successful for the antibodies used in this study, it is possible that antibodies with lower binding affinity might be eluted, in which case the pH could be increased. If this increases tissue argyrophilia to an unacceptable level, the duration of cysteine treatment can be extended.
Cysteine Treaunent Before Application of Peroxidase Complex and Subsequent DAB Reaction. The silver enhancement protocol of Liposits et al. (1984) calls for immunolabeling tissue with DAB before suppressing tissue argyrophilia. A disadvantage is that suppression of tissue argyrophilia also seemed to partially reduce DAB argyrophilia. Therefore, to maximize the sensitivity of the silver developer for DAB, tissue was cysteine-treated before the DAB reaction. Cysteine was applied after the biotinylated secondary antibody and before the ABC reagent.
Sodium Sulfide Pre-treatment Increases the Rate and Sensitivity of Silver Precipitation onto DAB. While looking for ways to maximize the sensitivity of the silver enhancement, we observed that pre-treatment of the DAB with sodium sulfide was very effective for this purpose. For these experiments, dot-blots were a convenient way to accurately predict the speed and extent of silver enhancement in tissue sections. Dot-blots consisted of squares of wet nitrocellulose spotted with 10 pl of diluted streptavidin-peroxidase complex (ABC-Elite reagent from Vector). These were rinsed, placed in a protein blocking solution, and the peroxidase visualized by brief exposure to 0.02% DAB plus 0.03% H202. When exposed to silver developer the brown spot of DAB turned black after 5 min. The rate of silver precipitation was increased by pre-treating the dot-blot with sodium sulfide for 5 min, in which case the spot turned black after 1.5 min.
In addition to increasing the rate of silver precipitation onto DAB, sodium sulfide also lowered the threshold of detection, as seen with low concentrations of DAB. To apply low concentrations of DAB to dot-blots, 0.02% aminoethylcarbazole (AEC) was used as a competitive substrate for the peroxidase reaction, applied along with DAB in 0.01 M acetate, pH 5 (for preparation of AEC see Wirsig and Leonard, 1986 ). On dot-blots reacted with 0.01% DAB plus AEC and then treated with sodium sulfide, silver enhancement was strong after 3 min. Without sodium sulfide the silver precipitation did not occur faster than background precipitation onto the nitrocellulose. With 0.02% DAB plus AEC, sodium sulfide decreased the time to intense silver enhancement from 8 to 2 min. Similar results were obtained when the competitive substrate AEC was replaced by 0.04% 4-chloro-1-naphthol reacted in 0.1 M Bis, pH 7.2. In summary, these experiments showed that sodium sulfide lowered the threshold of sensitivity and increased the rate of silver precipitation onto DAB. Sodium sulfide also had this effect in tissue sections, allowing silver precipitation on levels of DAB that were otherwise not visible by EM (see Results). In preliminary experiments without sodium sulfide, silver precipitation on such low levels of DAB in tissue sections was seen only with excessive silver development. which caused high levels of nonspecific silver precipitation.
In the above dot-blot experiments sodium sulfide was prepared (in a hood) as a 1% solution in DDW (titrated to pH 7 with 1 N HCI). Later dot-blot experiments showed that this solution could be diluted to a final concentration of 0.02% before there was a noticeable loss of effect on the rate of silver precipitation. Therefore, 0.10% was chosen as a suitable concentration for use in immunolabeled tissue.
Optimizing the Level of DAB and Silver Labeling in Tissue Sections. For the present method, the ideal amount of DAB in immunolabeled tissue is one that can be detected by silver enhancement but is not otherwise visible by EM. For this purpose, the concentration of DAB is adjusted so that only a few lightly labeled processes at the surface of the tissue can be visualized by LM, i.e., the LM threshold of detection. With this amount of DAB the vast majority of immunoreactive profiles are not visible with LM or EM until they are silver-enhanced. In practice, there is a limited range of DAB concentrations that provide optimal silver labeling. Too little DAB is not detected by the silver developer, and too much DAB causes DAB and/or silver deposits that obscure the labeled processes. In the latter case optimal labeling can sometimes be found by taking sections from deeper in the tissue, where labeling is less because of reduced antibody penetration. In addition to the concentration of DAB, the duration of silver development also affects the density of the final label. Our experiments were simplified by adopting a standard length of silver intensification (4.5-5 min) and manipulating the label density by changing the concentration of DAB.
The optimal concentration of DAB is determined as follows: after application of ABC, several sections are placed in vials with increasing concentrations of DAB in 0.1 M Bis buffer, pH 7.6. After 3-min pre-incubation, 0.03% H202 is added to each vial and after 3 min the reaction is stopped by replacing the solution with Tris buffer. The sections are then mounted on slides and inspected for label density. Once the LM threshold of detec-tion is determined. the remaining tissue can be reacted at that concenrration. Depending on antibody and tissue variables in different preparations. the optimal DAB concentration was typically between 0.001% and 0.007%.
Stabilization of Precipitated Silver. The precipitation of silver is stopped by transferring the tissue to 1% acetic acid. The silver is then stabilized by exposure to gold chloride followed by sodium thiosulfate (Liposits er al., 1984) . Excess exposure to gold chloride removes precipitated silver (Fai-r& et al., 1977) . Therefore, to maximize the sensitivity of the silver enhancement, we reduced the length of gold treatment from 10 to 2 min. Furthermore, to minimize diffusion of precipitated silver these srabilization steps were applied without interruption.
Recommended Procedure. (a) Tissue sections are pre-treated as usual to enhance antibody penetration (for example by freezing and thawing) and exposed to primary antibody for 2 days. Primary antibody concenrration is the same as used for conventional DAB labeling. Start with enough sections, keeping in mind that a few will be lost in determination of the optimal DAB concentration. (b) After several rinses in buffer. biotinylated secondary antibody is applied for 2 hr. (c) After several rinses in buffer, tissue is immersed for 5 hr in 5% cysteine in DDW (pH 2.75 with HCI). (d) Rinse tissue four times, several minutes each, in 2% sodium acetate in DDW (final pH 8.7) and then apply ABC reagent. made up in this buffer, for 1 hr. (e) Determine the visual threshold of DAB labeling as follows: after several rinses in 2% sodium acetate. the sections are left in this buffer except for sample sections. which are removed and placed in vials with ascending concentrations of DAB in 0.1 M Tris. pH 7.6. After 3 min add 0.03% H202 and after 3 more min stop the reaction by rinsing in Tris buffer. If the approximate optimal DAB concentration is not already known, start with a fairly wide range of DAB concentrations and do a second series to more precisely determine the optimal DAB concentration. The optimal concentration is near the threshold of detection by light microscopy, i.e.. where only a few surface processes are lightly labeled. (f) Rinse the remaining sections in 0.1 M Tris, pH 7.6. and react with the chosen DAB concenrration(s) for 3 min. After rinsing with 0.1 M Tris. pH 7.6. return the sections to 2 % sodium acetate. ( 9 ) In a hood, prepare a 0.10% solution of sodium sulfide in DDW, pH 7. It is convenient to first prepare a 1% solution and subsequently dilute it. (h) Rinse the sections briefly in DDW and apply the freshly prepared 0.10% sodium sulfide for 5 min. (i) Rinse several times in 2% sodium acetate. (j) Prepare the silver developer and with a clean glass rod transfer the tissue sections into the developer and leave for 4.5-5 min. (k) Transfer the sections to 1% acetic acid (in DDW) for 5 min. (I) Quickly rinse in 2% sodium acetate and apply 0.05% gold chloride in DDW for 2 min. (m) Quickly rinse in 2 % sodium acetate and apply 0.3% sodium thiosulfate in DDW for 5 min. (n) Transfer to phosphate buffer and process tissue for EM.
Results
Light Microscopic Appearance of SEDS Labeling
With all tissues and antibodies the LM distribution of label with the SEDS method appeared identical to that obtained with conventional DAB labeling. Labeling was restricted to fibers with the appearance and expected distribution of the different monoamine axon systems (Figure 2) . was not seen in cell bodies, and in all cases was eliminated by omission of the primary antibody. At high magnification, labeling was seen as a brown-gold label with black granular deposits, or simply as a black granular label. Label density varied from dense black near the tissue surface to a very fine granular Figure 2 . LM appearance of tissue prepared for EM by the SEDS immunolabeling technique. seen with dopamine immunoreactivity near the pial surface of the cerebral cortex. For demonstration purposes labeling is shown in a section with especially dense label. Samplesfor EM microscopy were taken from more lightly labeled processes. Immunoreactivity is seen in axons with the expected distribution and appearance of DAB-labeled dopamine immunoreactivity in this tissue. Bar = 30 um. deposition, except for a light granular deposit sometimes visible at the edge of the tissue section. Another type of background was seen only when tissue was subjected to excess periods of silver development (7-10 min instead of the recommended 4-5 min). Under these conditions there was sometimes a sporadic Golgi-like silver impregnation of glia, which was more common in lightly fixed tissue.
Electron Microscopic Appearance of SEDS Label
At the ultrastructural level, SEDS labeling was seen as dense black silver particles within the labeled processes (Figures 3-7) . Larger silver particles were about 20-100 nm in diameter and easily recognized at low magnification. At higher magnification smaller silver particles were often interspersed between the larger particles. Very light DAB labeling was visible in only a minority of processes. Following labeled processes in serial sections demonstrated that the silver particles were distributed within the processes and could also be detected even in fine intervaricose segments (e.g., Figure 3b ). Nonspecific silver deposition was relatively uncommon and was usually seen as isolated silver particles, easily distinguished from lalabel deeper in the tissue.
beled axons with multiple silver particles. A second, uncommon nonspecific label was seen in the form of "leakage" of silver from In all preparations there was little evidence of nonspecific silver labeled process into neighboring processes. Leakage was more common from heavily labeled processes or processes with broken membranes, and invariably was easily distinguished from the adjacent more dense specific label.
ELectron Microscopic Appearance of Monoamine Axons
All four populations of labeled monoamine axom were usually seen as varicose axons, with varicosities about 0.2-1 pm in diameter separated by thin intervaricose segments (Figures 3-7) . Varicosities tvpically contained one or more mitochondria, and it was not unusual to see long thin mitochondria in the intervaricose segments. Microtubules were sometimes seen in the intervaricose segments, but these were unusual and often seen as only one or two microtubules in a section. In all cortical monoamine systems, larger microtubulefilled mons were sometimes encountered, presumably representing parent axons that give rise to smaller varicose axons.
The punctate nature of the SEDS label allowed relatively unob- Figure 5 . Dopamine-immunoreactive axons in monkey anterior caudate form synapses (open arrows) on dendritic spines and shafts. Label is seen as punctate silver particles within immunoreactive axons. Caudate axons were also relatively filled with large clear vesicles but lacked densetore vesicles. (a) A dopamine synapse on a dendritic spine. This is a comparatively large dopamine synapse which could be identified in two to three serial sections. (b-e) A dopamine varicosity is seen in four serial sections, with a very fine synapse onto a dendritic shaft in c and d. Although the dopamine varicosity is relatively filled with synaptic vesicles, these are more dense near the site of membrane specialization.
which is seen as a slight widening of the extracellular space and straightening and densification of the cell membranes. Bar = 0.5 Ctm.
structed visualization of cell membranes and internal morphology. This allowed comparison of internal stmctures and simplified identification of synapses. In all cases synaptic vesicles were abundant in the varicosities and sometimes seen in the intervaricose segments. Although the density of vesicles increased presynaptically, confident identification of synapses required visualization of the associated membrane specializations, including increased straightening and densification of the pre-and postsynaptic membranes and widening of the extracellular space. Especially in dopamine and NE synapses, these membrane specializations were usually small and subtle and often seen clearly in only one serial section.
Dopamine Immunoreactivity in Prefrontal Cortex. In cerebral cortex dopamine axons were relatively filled with comparatively large clear synaptic vesicles, and less abundant dense-core vesicles (Figure 3) . Serial sectioning indicated that dense-core vesicles were present in almost all varicosities. Synapses were usually symmetrical and often quite subtle, although a rare asymmetric synapse was encountered. Dendritic spines and shafts were the common recipients of dopamine synapses.
Dopamine Immunoreactivity in the Anterior Caudate. Dopamine axons in the caudate were also filled with large clear synaptic vesicles but were never seen to contain dense-core vesicles (Figures  4 and 5) . They formed only symmetric synapses and, similar to the cortex, these were often quite small. Dendritic spines and shafts received dopamine synapses.
.. Figure6 . NE immunoreactivity in monkey prefrontal cortex. SEDS labeling is seen as punctate silver particles within the immunoreactive axon. NE axons appeared similar to dopamine axons, with many clear synaptic vesicles and more sparse dense-core vesicles (small arrows), and small symmetric synapses (open arrows). (a-c) Norepinephrine varicosity in three serial sections, forming a symmetric synapse onto a spine. The synapse reaches its largest diameter in a. is small in b, and is no longer present in c. (d-1) NE varicosity forming what appears to be a very fine synapse (open arrow in e) in a dendritic shaft. Although a few presynaptic vesicles are present, the synapse is most clearly identified by the fine membrane densification in e. Bar = 0.5 um. Norepinephrine Immunoreactivity in the Prekontal Cortex. NE! axons in the cerebral cortex were similar in appearance to cortical dopamine axons, containing many large clear synaptic vesicles and less abundant dense-core vesicles ( Figure 6 ). These axons also formed symmetric synapses, which were typically quite small. Dendritic spines and shafts received NE synapses.
Serotonin Immunoreactivity in the Prefrontal Cortex. 5HT immunoreactivity in the cerebral cortex was labeled with two different antibodies, in tissue fixed either in glutaraldehyde or mainly in paraformaldehyde (see Materials and Methods) . Labeled axons in both preparations had a very similar appearance (Figure 7) . They had abundant clear pleomorphic vesicles which appeared smaller than those of NE and dopamine axons, and they also had densecore vesicles. 5HT synapses were asymmetric, with a characteristic small but well-defined tuft of postsynaptic membrane density. SHT synapses were seen on dendritic shafts.
Discussion
We describe a novel silver-enhanced DAB-sulfide technique for high-resolution ultrastructural visualization of immunolabeled structures. The SEDS label consists of punctate silver deposits which are easily visualized, only minimally obscure intracellular structures, and can be used to identify even very small neural processes. Use of different antibodies, tissues, and fixatives demonstrates that this technique is reliable and reproducible. Although only anti-monoamine antibodies were used in this study, it is likely that SEDS will be applicable to a wide range of antibodies. As demonstrated with monoamine axons it will be especially useful in cases where small synaptic specializations are the subject of study.
The basis of this technique is the deposition of silver onto DABimmunolabeled processes, first described by Gallyas and colleagues (Gallyas et al., 1982; Gallyas 1971 Gallyas ,1982a , and then adapted for EM (Leranth and Pickel, 1989; Gorcs et al., 1986; van den Pol and Gorcs, 1986; Liposits et al., 1984) . The present protocol departs from previous ones in several ways. The principal innovation of the present technique is pre-treatment of DAB with sodium sulfide. Experiments both with dot-blots and in tissue sections demonstrated that sodium sulfide substantially increased the sensitivity of the silver developer for DAB. This allowed silver precipitation on levels of DAB below the threshold of visual detection by EM. Although preliminary attempts indicated that these experiments might be possible without sodium sulfide, lengthy periods of physical development were required, causing a high level of background silver. Sodium sulfide treatment allows consistent results with relatively short periods of silver enhancement.
Sulfide has previously been used to increase the sensitivity of silver precipitation onto heavy metals. This is the basis for Timm's staining of heavy metals (Timm, 1958) and a similar reaction is used in acetylcholinesterase histochemistry (Geneser-Jensen and Blackstad, 1971; Koelle, 1954) . In Timm's staining, heavy metals are precipitated by perfusing the animal with a sulfide solution, resulting in the formation of metal-sulfide complexes which are stable during subsequent tissue fixation. The metal-sulfides provide an active site for reduction and consequent precipitation of silver ions from a physical developer (Danscher, 1981; Brunk et al., 1968; Ti", 1958) . The observation that sulfide treatment increases silver precipitation onto DAB suggests that sulfide can also form complexes with polymerized DAB. The structure of the latter has been proposed to be a mixture of indamine and phenazine polymers (Seligman et al., 1968) which will react with a physical developer even without sulfide (Gallyas, 1982b) and which will bind a variety of heavy metals (Newman et al., 1983; Siegesmund et al., 1979) . Therefore, it is perhaps not surprising that polymerized DAB also binds sulfide. An alternative hypothesis is that sulfide is binding to some contaminating heavy metal which has itself bound to the DAB. This seems unlikely because we obtained very consistent results with the present protocol, even using several different batches of sodium sulfide and DAB.
Another modification from previous techniques was the use of cysteine instead of thioglycolic acid to suppress background tissue argyrophilia. In a systematic study of several mercapto compounds, Gallyas (1982b) showed that thioglycolic acid was most effective in suppressing tissue argyrophilia. However, the present experiments demonstrated that thioglycolic acid was incompatible with glutaraldehyde-fixed tissue. To overcome this problem, we found that cysteine was a very satisfactory replacement for thioglycolic acid, effectively suppressing tissue argyrophilia without damaging the ultrastructure. It has previously been noted that thioglycolic acid is also somewhat harmful to the ultrastructure of paraformaldehydefixed tissue (Liposits et al., 1986) , and it is possible that cysteine might be generally preferable for silver enhancement of DAB for EM.
Another departure from the previous techniques was the treatment of tissue for argyrophilia before rather than after the DAB reaction. This was done to maximize the sensitivity of the silver developer for DAB. Although it was not rigorously investigated, it was our impression that suppression of tissue argyrophilia by mercapto compounds also reduces DAB argyrophilia.
Types of Nonspecz& Silver Deposition
With all antibodies and tissue used the level of background label was quite low, simplifying the identification of specific label. Nonspecific deposition of silver probably arose from several causes. As with conventional DAB labeling on which SEDS labeling is based, endogenous peroxidases and nonspecific binding of antibodies undoubtedly accounted for some background silver precipitation. Also present was background peculiar to the SEDS technique, due to incomplete suppression of tissue argyrophilia. This probably accounted for some of the isolated silver particles in the tissue and for the silver deposition in glial cells seen with excess silver development. Although these sources of nonspecific labeling did not interfere with the present results, it is possible that other tissues will be more argyrophilic. Therefore, it is advisable to process control sections without primary antibody to exclude the presence of spurious labeling.
Another occasional source of nonspecific labeling was leakage of silver from labeled axons. Although it is possible that this arose from leakage of the DAB itself, our impression was that it was due to a temporary instability of the deposited silver. For this reason we recommend that the stabilization steps after silver enhancement be applied without delay. A similar leakage of silver is seen around Golgi-labeled cells (FairCn et al., 1977) . As with Golgi labeling, it is usually a simple matter to differentiate leaked silver from the heavier deposition of silver in the adjacent labeled process.
